These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 30139286)
1. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro. Chen X; Zha GF; Wang JQ; Liu XH J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286 [TBL] [Abstract][Full Text] [Related]
2. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656 [TBL] [Abstract][Full Text] [Related]
3. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects. Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. Sun J; Zhu H; Yang ZM; Zhu HL Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864 [TBL] [Abstract][Full Text] [Related]
6. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity. Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300 [TBL] [Abstract][Full Text] [Related]
7. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology. Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865 [TBL] [Abstract][Full Text] [Related]
8. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo. Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors. Fan ZF; Ho ST; Wen R; Fu Y; Zhang L; Wang J; Hu C; Shaw PC; Liu Y; Cheng MS Molecules; 2019 Sep; 24(17):. PubMed ID: 31480619 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells. Amin KM; Abou-Seri SM; Awadallah FM; Eissa AA; Hassan GS; Abdulla MM Eur J Med Chem; 2015 Jan; 90():221-31. PubMed ID: 25461322 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents. Alam MS; Lee DU Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety. Han X; Yu YL; Ma D; Zhang ZY; Liu XH J Enzyme Inhib Med Chem; 2021 Dec; 36(1):344-360. PubMed ID: 33356666 [TBL] [Abstract][Full Text] [Related]
13. Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin. Quan Wang J; Di Yang M; Chen X; Wang Y; Zeng Chen L; Cheng X; Hua Liu X J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1199-1211. PubMed ID: 30132373 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523 [TBL] [Abstract][Full Text] [Related]
15. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents. Chen TC; Yu DS; Huang KF; Fu YC; Lee CC; Chen CL; Huang FC; Hsieh HH; Lin JJ; Huang HS Eur J Med Chem; 2013 Nov; 69():278-93. PubMed ID: 24051300 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anticancer activity of N-(1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl derivatives. Gudisela MR; Srinivasu N; Mulakayala C; Bommu P; Rao MVB; Mulakayala N Bioorg Med Chem Lett; 2017 Sep; 27(17):4140-4145. PubMed ID: 28756024 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of celastrol derivatives as anticancer agents. Tang WJ; Wang J; Tong X; Shi JB; Liu XH; Li J Eur J Med Chem; 2015 May; 95():166-73. PubMed ID: 25812966 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents. Lv N; Sun M; Liu C; Li J Bioorg Med Chem Lett; 2017 Oct; 27(19):4578-4581. PubMed ID: 28888820 [TBL] [Abstract][Full Text] [Related]
20. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]